IIM
LXRX icon

INTECH Investment Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

INTECH Investment Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102K Buy
+42,491
New +$82.8K ﹤0.01% 1943
2025
Q2 		– Sell
-73,853
Closed -$34K – 2581
2025
Q1 		$34K Buy
73,853
+17,164
+30% +$10.8K ﹤0.01% 2469
2024
Q4 		$41.9K Sell
56,689
-16,751
-23% -$20.2K ﹤0.01% 2348
2024
Q3 		$115K Buy
+73,440
New +$131K ﹤0.01% 1865

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

INTECH Investment Management's LXRX Position: Q2 2026 in Review

INTECH Investment Management opened a new position in Lexicon Pharmaceuticals (LXRX) in Q2 2026: 42,491 shares worth $102K. The stake represents ﹤0.01% of the portfolio and ranks #1943 among its holdings. This is a return to the name: INTECH Investment Management previously reported a position in LXRX as recently as Q1 2025.

INTECH Investment Management first reported a position in LXRX in Q3 2024 and has held it in 4 quarters since. The position peaked at $115K in Q3 2024. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • INTECH Investment Management held 42,491 shares of Lexicon Pharmaceuticals worth $102K as of Q2 2026.
  • Lexicon Pharmaceuticals was a new INTECH Investment Management position in Q2 2026.
  • Lexicon Pharmaceuticals made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1943 holding.
  • INTECH Investment Management first reported a position in Lexicon Pharmaceuticals in Q3 2024 and has held it in 4 quarters since.
  • INTECH Investment Management's Lexicon Pharmaceuticals position peaked at $115K in Q3 2024.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.